Evidence map›Paper›PMID 39896430›Full record

ArticleRSC advances2025

Magnesium-ion-doped silica nanosheets as degradable drug carriers with enhanced antibacterial activity and cellular uptake.

Ruohan Liao, Chengdong Zhang, Zechuang Wang, Xingping Li, Chao Pu, Xuwei Luo, Gang Feng, Qiang Su, Dongqin Xiao

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in RSC advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ruohan LiaoResearch Institute of Tissue Engineering and Stem Cells, Department of Pharmacy, The Second Clinical College of North Sichuan Medical College Nanchong Sichuan 637000 China xiaodongqin@nsmc.edu.cn 187169442@qq.com.ORCID https://orcid.org/0009-0001-3089-0660
Chengdong ZhangResearch Institute of Tissue Engineering and Stem Cells, Department of Pharmacy, The Second Clinical College of North Sichuan Medical College Nanchong Sichuan 637000 China xiaodongqin@nsmc.edu.cn 187169442@qq.com.
Zechuang WangResearch Institute of Tissue Engineering and Stem Cells, Department of Pharmacy, The Second Clinical College of North Sichuan Medical College Nanchong Sichuan 637000 China xiaodongqin@nsmc.edu.cn 187169442@qq.com.
Xingping LiDepartment of Orthopaedics, Chengfei Hospital Chengdu Sichuan 610091 China.
Chao PuResearch Institute of Tissue Engineering and Stem Cells, Department of Pharmacy, The Second Clinical College of North Sichuan Medical College Nanchong Sichuan 637000 China xiaodongqin@nsmc.edu.cn 187169442@qq.com.
Xuwei LuoResearch Institute of Tissue Engineering and Stem Cells, Department of Pharmacy, The Second Clinical College of North Sichuan Medical College Nanchong Sichuan 637000 China xiaodongqin@nsmc.edu.cn 187169442@qq.com.
Gang FengResearch Institute of Tissue Engineering and Stem Cells, Department of Pharmacy, The Second Clinical College of North Sichuan Medical College Nanchong Sichuan 637000 China xiaodongqin@nsmc.edu.cn 187169442@qq.com.
Qiang SuResearch Institute of Tissue Engineering and Stem Cells, Department of Pharmacy, The Second Clinical College of North Sichuan Medical College Nanchong Sichuan 637000 China xiaodongqin@nsmc.edu.cn 187169442@qq.com.
Dongqin XiaoResearch Institute of Tissue Engineering and Stem Cells, Department of Pharmacy, The Second Clinical College of North Sichuan Medical College Nanchong Sichuan 637000 China xiaodongqin@nsmc.edu.cn 187169442@qq.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mesoporous silica nanoparticles (MSNs) have attracted significant interest in drug delivery applications due to their good biocompatibility and high specific surface area. However, conventional MSNs typically have small pore sizes and low degradation rates, resulting in limited drug loading capacity and potential

Identifiers

PMID39896430
PMCPMC11783045

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.